Previous close | 46.16 |
Open | 49.01 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 49.01 - 49.01 |
52-week range | 42.23 - 56.63 |
Volume | |
Avg. volume | 140 |
Market cap | 5.693B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 28.83 |
EPS (TTM) | 1.70 |
Earnings date | 22 Feb 2024 |
Forward dividend & yield | 1.44 (3.12%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost long-term wealth. The post 2 FTSE 100 shares investors should consider buying for a winning portfolio appeared first on The Motley Fool UK.